Wed, Aug 20, 2014, 5:43 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • clsnphase3 clsnphase3 Sep 12, 2012 10:08 AM Flag

    CLSN could be a $30 name in 2013

    Liver, and potential use in Breast & Lung Cancer treatment.

    This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.

    Thermodox is smacking these tumors in a GOOD way. HEAT Trials/Data should show this.

    I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.

    Do your DD ; Shorts are trying to stop this advance but I believe institutions will buy any dip. Don't get stopped. This stock is going much higher.

    Sentiment: Strong Buy

 
KERX
16.18-0.04(-0.25%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.